InnovaRx Innova Health Strategies

J15.69

Pneumonia due to other Gram-negative bacteria

Billable FY2026 2025-10-01 → 2026-09-30
Exclusions 22 never code together
J15code
Excludes1
  • chlamydial pneumonia (J16.0)J16.0
  • congenital pneumonia (P23.-)P23.-
  • Legionnaires' disease (A48.1)A48.1
  • spirochetal pneumonia (A69.8)A69.8
J09-J18block
Excludes2
  • allergic or eosinophilic pneumonia (J82)J82
  • aspiration pneumonia NOS (J69.0)J69.0
  • meconium pneumonia (P24.01)P24.01
  • neonatal aspiration pneumonia (P24.-)P24.-
  • pneumonia due to solids and liquids (J69.-)J69.-
  • congenital pneumonia (P23.9)P23.9
  • lipid pneumonia (J69.1)J69.1
  • rheumatic pneumonia (I00)I00
  • ventilator associated pneumonia (J95.851)J95.851
J00-J99chapter
Excludes2
  • certain conditions originating in the perinatal period (P04-P96)P04-P96
  • certain infectious and parasitic diseases (A00-B99)A00-B99
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
  • endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
  • injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
  • neoplasms (C00-D49)C00-D49
  • smoke inhalation (T59.81-)T59.81-
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 16
J15code
Includes
  • bronchopneumonia due to bacteria other than S. pneumoniae and H. influenzae
Code first
Code also
  • , if applicable, any associated condition such as:
  • abscess (J85.1)J85.1
  • aspiration pneumonia (J69.-)J69.-
J15.69code
Inclusion terms
  • Pneumonia due to other aerobic Gram-negative bacteria
  • Pneumonia due to Serratia marcescens
J09-J18block
Use additional code
  • code, if applicable, to identify resistance to antimicrobial drugs (Z16.-)Z16.-
J00-J99chapter
Notes
  • When a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).J40
Use additional code
  • code, where applicable, to identify:
  • exposure to environmental tobacco smoke (Z77.22)Z77.22
  • exposure to tobacco smoke in the perinatal period (P96.81)P96.81
  • history of tobacco dependence (Z87.891)Z87.891
  • occupational exposure to environmental tobacco smoke (Z57.31)Z57.31
  • tobacco dependence (F17.-)F17.-
  • tobacco use (Z72.0)Z72.0
Index entries leading here 1
  • Pneumonia (acute) (double) (migratory) (purulent) (septic) (unresolved) J18.9
    • in (due to)
    • broncho-, bronchial (confluent) (croupous) (diffuse) (disseminated) (hemorrhagic) (involving lobes) (lobar) (terminal) J18.0
    • Enterobacter J15.69
    • gram-negative bacteria NEC J15.69
    • lobar (disseminated) (double) (interstitial) J18.1
    • Proteus J15.69
    • Serratia marcescens J15.69
Alongside this code 1 same parent — J15.6
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC114 CMS28HCC282 ESRD21HCC114 ESRD24HCC114

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
J15.6
Block
J09-J18
Siblings
1

Present FY2024–FY2027.